Search

everythinglearnresearchcommunity

for

Search:↓

Ritlecitinib is being tested for effectiveness and safety in treating severe alopecia areata.

Guselkumab significantly improves psoriasis symptoms within 12 weeks.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

Ritlecitinib effectively promotes hair regrowth in severe and very severe alopecia areata.

Ixekizumab is effective and safe for patients who did not improve with etanercept treatment for psoriasis.

Baricitinib helps long-term hair regrowth in severe alopecia areata patients.

Deuruxolitinib significantly improves hair satisfaction in severe alopecia areata patients.

The gene therapy showed significant wound healing and was safe for treating severe RDEB.

Ritlecitinib is effective for long-term treatment of severe alopecia areata.

JAK inhibitors offer new hope for treating severe alopecia areata.

Ozenoxacin 1% cream is an effective and safe treatment for impetigo in children and adults.

A new hair restoration technology was found to effectively increase hair thickness, density, and growth, while reducing hair loss and improving scalp health, with no side effects.

The topical inhibitor CUR61414 was not effective in treating basal cell carcinoma in human trials.

Aleglitazar and its major metabolite are safe enough to proceed to Phase 3 clinical trials.

The treatment increased hair follicle counts and is potentially effective for male hair loss without serious side effects.

The ayurvedic hair oil is safe and effective for reducing hair fall, promoting hair growth, and improving scalp health.

Brepocitinib effectively reduces inflammation and improves symptoms in cicatricial alopecia with good safety.

Baricitinib is generally safe for long-term use in treating severe alopecia areata.

Electric stimulation at 448 kHz can promote hair growth by enhancing cell activity in hair follicles.

Increasing the dose of baricitinib to 4 mg helps more patients with severe alopecia areata regrow hair.

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Baricitinib is an effective treatment for severe alopecia areata.

Upadacitinib helps most people with alopecia regrow hair quickly and is generally safe.

The new clinical trial design is promising but needs real-world trials to test its effectiveness and possible enhancements.

MK-0773 safely increased muscle mass but did not improve muscle strength or function in elderly women with sarcopenia.

Injections of special skin cells showed potential in treating hair loss, with some participants experiencing increased hair density.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Tavaborole is a safe and effective toenail fungus treatment, with the 5% solution being the best option.

Spironolactone may help reduce hair loss in androgenic alopecia.